Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000820759 | SCV000961486 | pathogenic | not provided | 2024-12-29 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 349 of the SLC12A3 protein (p.Pro349Leu). This variant is present in population databases (rs121909383, gnomAD 0.007%). This missense change has been observed in individuals with Gitelman's syndrome (PMID: 8528245, 8900229, 21415153). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8592). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SLC12A3 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000009123 | SCV002811075 | pathogenic | Familial hypokalemia-hypomagnesemia | 2024-01-05 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000009123 | SCV000029340 | pathogenic | Familial hypokalemia-hypomagnesemia | 1996-01-01 | no assertion criteria provided | literature only | |
Natera, |
RCV000009123 | SCV002089340 | likely pathogenic | Familial hypokalemia-hypomagnesemia | 2021-03-18 | no assertion criteria provided | clinical testing |